Contract Research Organizations Global Market Opportunities And Strategies To 2021

Tuesday, August 14, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, August 14, 2018 /PRNewswire/ -- Contract Research Organizations Global Market Opportunities And Strategies By Type Of Services: Drug Discovery, Preclinical Studies, Phase 1, Phase 2, Phase 3, Phase 4 and Others; By Therapeutic Area - Oncology, Cardiovascular Disease, CNS Disorder, Infectious Disease, Metabolic Disease and Others; With Forecast Until 2021

Read the full report: https://www.reportlinker.com/p05482360 Executive SummaryA Contract Research Organization (CRO) is a service provider, which offers end-to-end solutions in conducting clinical trials for biopharmaceutical and medical
device companies. The core services offered by CROs to biopharmaceutical companies include initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services. Many pharmaceutical companies often outsource their R&D activities to CROs and is expected that these companies will increase their outsourcing activities for drug development process to CROs in future.The CRO production in the North America is worth $18.8 billion accounting for 42.3% of the global CRO production, while the CRO consumption in the North America is worth $20.8 billion which accounted for about 46.8% of the global CRO consumption. The large market size can be attributed to the presence of a large number of pharmaceutical companies and large drug development activity in the region. The difference can be explained by the use of lowercost offshore locations for some CRO activities by US pharmaceutical firms, although the majority of outsourced activity remains within the US market. By service type, drug discovery was the largest segment in 2017, which accounted for about 33.2% of the CRO market. By therapeutic area, oncology was the largest segment in 2017, which accounted for about 25.1% of the CRO market.The declining growth of the pharmaceutical market is affecting the CRO industry. Recently, the double digit growth rates of pharmaceutical and biotechnology companies have been shrinking to single digit and R&D productivity also declining owing to drug launch delays and FDA rejections in approval of drugs. Pharmaceutical and biotechnology companies have been encountered with the major task of minimizing their drug costs which had forced most of them to evaluate cost saving options such as outsourcing. Several companies in this sector have already adopted this strategy to outsource their processes to specialist service providers such as CROs. This strategy will help the players to free up their in-house resources for other crucial projects and bring about improved efficiency in terms of timelines, regulatory norms and costs.Some of the other major trends in the CRO industry include the following – • Increasing focus on emerging markets such as China, India and Brazil.• Strategic partnerships between CROs and their sponsors• Growing investments in technologyIQVIA was the largest player in the global CRO market with 12.4% share, followed by Laboratory Corporation of America Holdings, ICON Plc, PAREXEL and PPD.DescriptionWhere is the largest and fastest growing market for CRO? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CRO global market report from the Business Research Company answers all these questions and many more.The report covers market characteristics, size and growth, porters five force model, segmentation, regional and country breakdowns, competitive landscape, market shares, customer information, key mergers and acqisitions, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.• The market characteristics section of the report defines and explains the market.• The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints cover the external factors supporting and controlling the growth of the market.• Porters five force model covers the threat of new entrants, threat of substitutes, bargaining power of buyers, bargaining power of suppliers and industry competition for the CRO market.• Market segmentation by service breaks down the market into sub markets. By service type, the market is segmented into drug discovery, preclinical studies, phase 1, phase 2, phase 3 ,phase 4, others . Market segmentation is also done by type of therapeutic area, which includes oncology, cardiovascular disease, CNS disorder, infectious disease, metabolic disease and others. The historic and forecast growth rates for these segments are also covered in this report.• The regional and country breakdown section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets.• The competitive landscape section gives a description of the competitive nature of the market, market shares, and a description of the leading companies in terms of their offerings, growth strategy and financial performance.• The customer information section covers major surveys conducted on the global CRO market and their implications.• The report also covers key mergers and acquisitions in the CRO market. Key financial deals which have shaped the market in recent years are identified.• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.ScopeMarkets covered: 1) By Type of Services - drug discovery, preclinical studies, phase 1, phase 2, phase 3 ,phase 4 and others 2) By Therapeutic Area - oncology, cardiovascular disease, CNS disorder, infectious disease, metabolic disease and othersCompanies mentioned: IQVIA, Laboratory Corporation of America Holdings, ICON Plc , PAREXEL and PPD.Countries: USA, UK, Germany, France, Italy, Spain, Russia, Brazil, Australia, China, India, JapanRegions: Asia-Pacific, North America, South America, Western Europe, Eastern Europe, Middle East & Africa.Time series: Five years historic and forecast.Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.The report covers production and consumption revenue data for CROs providing outsourced pharmaceutical, biologics and medical research services. Production revenues are based on where the services are produced, e.g the country where the CRO services occur. Consumption revenues are based on where the services are sold irrespective of where the goods or services are produced. This differentiation affects only where revenues are recognized by geography and does not apply to the global numbers.Why this report?Timely And Critical:- Expensive clinical trials failures- Stringent and differing government regulations- Increasing forcus on the emerging markets- Implementation of the real world evidence in clinical trials- Increase in the mergers and acquisitions activities- Outsourcing fpr a pharmaceutical company to CRO - an opportunity to focus on core capabilitiesReasons to Purchase• Outperform competitors using accurate up to date demand-side dynamics information.• Identify growth segments for investment.• Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.• Create regional and country strategies on the basis of local data and analysis.• Stay abreast of the latest customer and market research findings• Benchmark performance against key competitors.• Develop strategies based on likely future developments.• Utilize the relationships between key data sets for superior strategizing.• Suitable for supporting your internal and external presentations with reliable high quality data and analysis• Gain a global perspective on the development of the market.Read the full report: https://www.reportlinker.com/p05482360 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/contract-research-organizations-global-market-opportunities-and-strategies-to-2021-300696819.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store